ATX
DEAD

Serial Number

79386489

Owner

AlgoTherapeutix

Filing Date

Nov 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ATX Trademark

Serial Number: 79386489

ATX is a trademark filed by AlgoTherapeutix on November 9, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AlgoTherapeutix (5 trademarks)

49 rue des Nouvelles

Entity Type: 34

Trademark Details

Filing Date

November 9, 2023

Registration Date

Not Registered

Goods & Services

Scientific and technical research services; technical project studies; scientific laboratory services; carrying out clinical trials for pharmaceutical products; provision of information concerning the results of clinical trials for pharmaceutical products; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials; biological, clinical and medical research; clinical research; carrying out clinical trials; research in the field of medicines; development of pharmaceutical preparations and medicines; research and development of medicines; research and development of pharmaceutical products; laboratory research services concerning pharmaceutical products; consultancy with respect to pharmaceutical research and development; consulting relating to pharmacology; consultancy in the field of pharmaceutical research; services for conducting early assessments of new pharmaceuticals; all these services being intended to be offered for the treatment of complex pain

Pharmaceutical products; veterinary products; chemical preparations for medical use; pharmaceutical preparations; chemico-pharmaceutical products; pharmaceutical substances; medicines; pharmaceutical solutions; diagnostic agents for medical use; chemical products for pharmaceutical use; chemical reagents for medical use; chemical reagents for veterinary use; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical analysis reagents for medical use; chemical analysis reagents for veterinary use; pharmaceuticals for the treatment of rare diseases; all these products being intended for use in the treatment of complex pain

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 26, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 6, 2025 ABN2
ASSIGNED TO EXAMINER
Aug 16, 2024 DOCK
REFUSAL PROCESSED BY IB
Aug 11, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 23, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR